UK markets open in 3 hours 46 minutes

Compass Therapeutics, Inc. (CMPX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
3.55000.0000 (0.00%)
At close: 12:21PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5219.02M
Enterprise value 3195.74M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)7.59
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7-7.11

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-52.00%
S&P500 52-week change 334.12%
52-week high 311.0000
52-week low 33.5300
50-day moving average 34.1714
200-day moving average 35.2962

Share statistics

Avg vol (3-month) 33.52k
Avg vol (10-day) 3N/A
Shares outstanding 561.69M
Implied shares outstanding 6N/A
Float 31.57M
% held by insiders 12.90%
% held by institutions 120.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-32.92%
Return on equity (ttm)-196.68%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -27.51M
Net income avi to common (ttm)-80.76M
Diluted EPS (ttm)-1.5710
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)31.21M
Total cash per share (mrq)0.51
Total debt (mrq)10.26M
Total debt/equity (mrq)35.55
Current ratio (mrq)4.11
Book value per share (mrq)0.47

Cash flow statement

Operating cash flow (ttm)-25.29M
Levered free cash flow (ttm)-15.62M